{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Morgantown",
      "state": "WV",
      "country": "United States",
      "classification": "Class II",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "79955",
      "recalling_firm": "Mylan Pharmaceuticals Inc.",
      "address_1": "781 Chestnut Ridge Rd",
      "address_2": "N/A",
      "postal_code": "26505-2730",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Product was distributed throughout the United States, including Puerto Rico.",
      "recall_number": "D-0825-2018",
      "product_description": "Loxapine Capsules, USP  50 mg, Rx Only,  100-count bottles, NDC 0378-7050-01",
      "product_quantity": "11,650 bottles",
      "reason_for_recall": "CGMP Deviations",
      "recall_initiation_date": "20180424",
      "center_classification_date": "20180522",
      "termination_date": "20190814",
      "report_date": "20180530",
      "code_info": "NDC 0378-7050-01    Lot Numbers:  3079386, Exp. 10/31/18  3079387, Exp. 10/31/18  3079388, Exp. 10/31/18  3083762, Exp. 3/31/19  3083763, Exp. 3/31/19  3083764, Exp. 3/31/19  3083765, Exp. 3/31/19  3083766, Exp. 3/31/19  3083767, Exp. 3/31/19"
    }
  ]
}